Efficacy and immune modulation associated with the addition of IMiDs to Daratumumab backbone in multiple myeloma patients refractory to both drug classes: resetting synergistic activity
在对达雷妥尤单抗和免疫调节剂均耐药的多发性骨髓瘤患者中,联合使用免疫调节剂(IMiDs)可增强疗效并改善免疫调节:重置协同活性
期刊:Blood Cancer Journal
影响因子:11.6
doi:10.1038/s41408-024-00988-x
Kostopoulos, Ioannis V; Fotiou, Despina; Gavriatopoulou, Maria; Rousakis, Pantelis; Ntanasis-Stathopoulos, Ioannis; Panteli, Chrysanthi; Malandrakis, Panagiotis; Migkou, Magdalini; Angelis, Nikolaos; Kanellias, Nikolaos; Eleutherakis-Papaiakovou, Evangelos; Theodorakakou, Foteini; Krevvata, Maria; Terpos, Evangelos; Dimopoulos, Meletios-Athanasios; Tsitsilonis, Ourania; Kastritis, Efstathios